224 related articles for article (PubMed ID: 17395129)
1. Challenges in the design and conduct of therapeutic trials in channel disorders.
Venance SL; Herr BE; Griggs RC
Neurotherapeutics; 2007 Apr; 4(2):199-204. PubMed ID: 17395129
[TBL] [Abstract][Full Text] [Related]
2. Muscle channelopathies: the nondystrophic myotonias and periodic paralyses.
Statland JM; Barohn RJ
Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1598-614. PubMed ID: 24305449
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.
Platt D; Griggs R
Curr Opin Neurol; 2009 Oct; 22(5):524-31. PubMed ID: 19571750
[TBL] [Abstract][Full Text] [Related]
4. State of the art in hereditary muscle channelopathies.
Jurkat-Rott K; Lehmann-Horn F
Acta Myol; 2010 Oct; 29(2):343-50. PubMed ID: 21314017
[TBL] [Abstract][Full Text] [Related]
5. Familial Episodic Ataxias and Related Ion Channel Disorders.
Jen J
Curr Treat Options Neurol; 2000 Sep; 2(5):429-431. PubMed ID: 11096768
[TBL] [Abstract][Full Text] [Related]
6. CACNA1A-Related Channelopathies: Clinical Manifestations and Treatment Options.
Indelicato E; Boesch S
Handb Exp Pharmacol; 2023; 279():227-248. PubMed ID: 36592223
[TBL] [Abstract][Full Text] [Related]
7. Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system.
Ptácek LJ
Neuromuscul Disord; 1997 Jun; 7(4):250-5. PubMed ID: 9196907
[TBL] [Abstract][Full Text] [Related]
8. Drug repurposing in skeletal muscle ion channelopathies.
Altamura C; Saltarella I; Campanale C; Laghetti P; Desaphy JF
Curr Opin Pharmacol; 2023 Feb; 68():102329. PubMed ID: 36512979
[TBL] [Abstract][Full Text] [Related]
9. Calcium channelopathies in inherited neurological disorders: relevance to drug screening for acquired channel disorders.
Lory P; Mezghrani A
IDrugs; 2010 Jul; 13(7):467-71. PubMed ID: 20582871
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis.
Raja Rayan DL; Hanna MG
Curr Opin Neurol; 2010 Oct; 23(5):466-76. PubMed ID: 20634695
[TBL] [Abstract][Full Text] [Related]
11. Muscle channelopathies: recent advances in genetics, pathophysiology and therapy.
Suetterlin K; Männikkö R; Hanna MG
Curr Opin Neurol; 2014 Oct; 27(5):583-90. PubMed ID: 25188014
[TBL] [Abstract][Full Text] [Related]
12. Muscle Channelopathies.
Trivedi JR
Continuum (Minneap Minn); 2022 Dec; 28(6):1778-1799. PubMed ID: 36537980
[TBL] [Abstract][Full Text] [Related]
13. Muscle channelopathies and electrophysiological approach.
Cherian A; Baheti NN; Kuruvilla A
Ann Indian Acad Neurol; 2008 Jan; 11(1):20-7. PubMed ID: 19966974
[TBL] [Abstract][Full Text] [Related]
14. Episodic ataxia and channelopathies.
Gordon N
Brain Dev; 1998 Jan; 20(1):9-13. PubMed ID: 9533553
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
Al-Ghamdi F; Darras BT; Ghosh PS
Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
[TBL] [Abstract][Full Text] [Related]
16. The primary periodic paralyses: diagnosis, pathogenesis and treatment.
Venance SL; Cannon SC; Fialho D; Fontaine B; Hanna MG; Ptacek LJ; Tristani-Firouzi M; Tawil R; Griggs RC;
Brain; 2006 Jan; 129(Pt 1):8-17. PubMed ID: 16195244
[TBL] [Abstract][Full Text] [Related]
17. [Muscle channelopathies. Myotonias and periodic paralyses].
Jurkat-Rott K; Lerche H; Lehmann-Horn F
Nervenarzt; 2011 Apr; 82(4):511-20; quiz 521. PubMed ID: 21484581
[TBL] [Abstract][Full Text] [Related]
18. Novel insights into the pathomechanisms of skeletal muscle channelopathies.
Burge JA; Hanna MG
Curr Neurol Neurosci Rep; 2012 Feb; 12(1):62-9. PubMed ID: 22083238
[TBL] [Abstract][Full Text] [Related]
19. Muscle channelopathies.
Saperstein DS
Semin Neurol; 2008 Apr; 28(2):260-9. PubMed ID: 18351527
[TBL] [Abstract][Full Text] [Related]
20. Muscle channelopathies.
Statland J; Phillips L; Trivedi JR
Neurol Clin; 2014 Aug; 32(3):801-15, x. PubMed ID: 25037091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
